Patents by Inventor Zhenxing XU

Zhenxing XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10249302
    Abstract: A method for recognizing time information from speech data includes: obtaining text information corresponding to speech data; identifying a first time feature contained in the speech data based on the text information; searching within a respective configuration file corresponding to the first time feature to obtain a corresponding time identifier for the first time feature; assigning the corresponding time identifier to a field that is in intermediate time data and that corresponds to the respective configuration file in which the first time feature is located, the intermediate time data comprising multiple fields, and each field being corresponding to a respective configuration file of a plurality of configuration files, each of the plurality of configuration files corresponding a respective category related to time; and obtaining, according to content of one or more fields in the intermediate time data, system time data corresponding to the time information contained in the speech data.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: April 2, 2019
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Fei Wang, Hao Xu, Xiaobing Feng, Zhenxing Xu, Guodong Pei
  • Patent number: 9878035
    Abstract: Disclosed is a composition comprising: i) HBsAg, a fragment thereof, a variant thereof, or the mixture of at least two of them, ii) HBcAg1-X, a fragment thereof, a variant of the antigen or the antigen fragment, or the mixture of at least two of them, wherein X is an integer of from 149 to 183, iii) CpG-ODN, 21 bases long, which is a phosphorothioate oligonucleotide and includes two or more copies of 5?-NTCGTT-3? motifs. The use of the composition in the treatment of HBV-infection and HBV-induced diseases, and the therapy methods of HBV-infection and HBV-induced diseases are also disclosed.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: January 30, 2018
    Assignee: JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
    Inventors: Sean Xiaohan Du, Jun Ge, Xiaoqian Zhuang, Tong Zhou, Jianqiang Li, Cuiling Song, Ying Sun, Meiju Wang, Yue Gu, Honglin Sun, Zhenxing Xu, Hongying Huang, Xiaoxiao Chen
  • Publication number: 20170372702
    Abstract: A method for recognizing time information from speech data includes: obtaining text information corresponding to speech data; identifying a first time feature contained in the speech data based on the text information; searching within a respective configuration file corresponding to the first time feature to obtain a corresponding time identifier for the first time feature; assigning the corresponding time identifier to a field that is in intermediate time data and that corresponds to the respective configuration file in which the first time feature is located, the intermediate time data comprising multiple fields, and each field being corresponding to a respective configuration file of a plurality of configuration files, each of the plurality of configuration files corresponding a respective category related to time; and obtaining, according to content of one or more fields in the intermediate time data, system time data corresponding to the time information contained in the speech data.
    Type: Application
    Filed: September 7, 2017
    Publication date: December 28, 2017
    Inventors: Fei WANG, Hao XU, Xiaobing FENG, Zhenxing XU, Guodong PEI
  • Publication number: 20160136264
    Abstract: Disclosed is a composition comprising: i) HBsAg, a fragment thereof, a variant thereof, or the mixture of at least two of them, ii) HBcAg1-X, a fragment thereof, a variant of the antigen or the antigen fragment, or the mixture of at least two of them, wherein X is an integer of from 149 to 183, iii) CpG-ODN, 21 bases long, which is a phosphorothioate oligonucleotide and includes two or more copies of 5?-NTCGTT-3? motifs. The use of the composition in the treatment of HBV-infection and HBV-induced diseases, and the therapy methods of HBV-infection and HBV-induced diseases are also disclosed.
    Type: Application
    Filed: February 26, 2014
    Publication date: May 19, 2016
    Applicant: JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
    Inventors: Sean Xiaohan DU, Jun GE, Xiaoqian ZHUANG, Tong ZHOU, Jianqiang LI, Cuiling SONG, Ying SUN, Meiju WANG, Yue GU, Honglin SUN, Zhenxing XU, Hongying HUANG, Xiaoxiao CHEN